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Abstract
Background : The eosinophil cationic protein (ECP) is cytotoxic to bacteria, viruses, parasites and mammalian cells.
Cells are damaged via processes of pore formation, permeability alteration and membrane leaking. Some clinical
studies indicate that ECP gathers in the bronchial tract of asthma sufferers, damages bronchial and airway epithelial
cells, and leads to in breathing tract inflammation; therefore, prevention of the cytotoxicity caused by ECP may
serve as an approach to treat airway inflammation. To achieve the purpose, reduction of the ECP-cell interactions is
rational. In this work, the Chinese herbal combinative network was generated to predict and identify the functional
herbs from the pools of prescriptions. It was useful to select the node herbs and to demonstrate the relative
binding ability between ECP and Beas-2B cells with or withour herb treatments.
Results : Eighty three Chinese herbs and prescriptions were tested and five effective herbs and six prescription
candidates were selected. On the basis of effective single-herbal drugs and prescriptions, a combinative network
was generated. We found that a single herb, Gan-cao, served as a node connecting five prescriptions. In addition,
Sheng-di-huang, Dang-guei and Mu-tong also appeared in five, four and three kinds of prescriptions, respectively.
The extracts of these three herbs indeed effectively inhibited the interactions between ECP and Beas-2B cells.
According to the Chinese herbal combinative network, eight of the effective herbal extracts showed inhibitory
effects for ECP internalizing into Beas-2B cells. The major components of Gang-cao and Sheng-di-huang,
glycyrrhizic acid and verbascose, respectively, reduced the binding affinity between ECP and cells effectively.
Conclusions : Since these Chinese herbs reduced the binding affinity between ECP and cells and inhibited
subsequent ECP entrance into cells, they were potential for mitigating the airway inflammation symptoms.
Additionally, we mentioned a new concept to study the Chinese herbs using combinative network in the field of
systems biology. The functional single herbs could be identified from the set of prescriptions.
Introduction
Eosinophil cationic protein (ECP) is a human protein
secreted from activated eosinophils and released into
biological fluid under inflammatory conditions [1]. It
belongs to the ribonuclease A (RNaseA) superfamily
which is composed of structure- and sequence-related
members that possess hydrolytic activities towards poly-
meric ribonucleic acids (RNA) for regulating gene
expression at the mRNA level [2]. Nine human proteins
with significant sequence similarities to bovine pancrea-
tic RNaseA, the first isolated RNase, are grouped into
the human RNaseA superfamily and are named from
RNase1 to RNase9 [3-5]. Within this protein superfamily
are two categories: one possesses high ribonucleolytic
activity, including RNase1, RNase2, RNase4, RNase6,
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any medium, provided the original work is properly cited.Figure 1 Herbal extract effects on ECP-cell binding affinity. The comparison of MBP and MBP-ECP interactions with Beas-2B cells (A). Partial
results of MBP-ECP-cell interaction in the presence of 0.1% (B) and 0.01% (C) herbs. The line shown in (B) means the relative fold less than 10%.
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Page 2 of 11and RNase8, and the other is cytotoxic towards bacteria,
parasites, or mammalian cells, such as RNase3 (ECP),
RNase7 and RNase9 [4,6-8]. Structurally, ECP folds
topology containing 3 a-helices and 5 b-strands [9]. It is
a highly positively-charged protein due to its high Arg
content (19 Args, pI=10.8), which promotes interactions
between ECP and the molecules with negative charges
on the cell surface, such as proteoglycan, heparin sulfate
and lipid molecules [10,11]. Through the interactions
with organism surface, ECP translocates into cells and
causes cell damage [12]. In addition to cytotoxicty, ECP
also displays antimicrobial activities against bacteria,
single strand RNA viruses, and helminth parasites and
mammalian cells [13-15]. Recent reports have men-
tioned that the N-terminus of ECP is bactericidal and
disrupts lipid membrane of the target cells [16].
Some hypothesized mechanisms of ECP-triggered cell
damage suggested that ECP destabilized cell membrane
via processes of pore formation, permeability alterations
and membrane leaking [11]. ECP contributed to tissue
damage with regards to bronchial asthma [17] or the
intestinal mucosa in Crohn’s disease [18]. In clinical
diagnosis, it has been used as a biomarker for determi-
nation of the severity of airway inflammatory diseases,
such as asthma [17]. The ECP level in serum also
increased during a pathogen infection, such as toxocara
[19] and cystic hydatidosis [20]. During airway inflam-
mation, ECP was a common feature to indicate bron-
chial epithelial cell damage [21]. It was also reported to
damage Beas-2B cells through the apoptosis mechanisms
of caspase 8 [22]. We have reported that the carboxy-
peptidase E (CPE) and heparan sulfate proteoglycans
served as receptor-like molecules for ECP binding to
cell membrane and translocating into neuroendocrine
cells [23] and bronchial epithelial cells [12], respectively.
In 2008, the heparin binding residues in ECP were also
identified and characterized [24].
Since cell damage caused by ECP is one of the signifi-
cant features of airway inflammation, it is of great inter-
est in discovering practical substance to neutralize the
cytotoxicity of ECP. As is known, the cytotoxicity of
ECP can be blocked by specific antibodies and heparin
in vitro [20,24], the aim of this study is to employ com-
binative network analysis to discover a potent substance
which has been widely used and is effective for inhibit-
ing the cytotoxicity of ECP. This methodology assisted
in identifying the potent effective components from pre-
scriptions or herbs; therefore, the herbal variety may be
decreased and the formulation of drugs can be simpli-
fied. Similar to the strategy, the combinative therapy is
used. The combinative therapy can present synergistic
effect to strengthen the drug efficacy but using less drug
dosage. This therapy concept is similar to the treatment
of traditional Chinese medicine, in which prescriptions
are formulated from single herbs. In addition, the sys-
tems biology approaches for studying combinative ther-
apy have been established in the levels of genome wide
transcriptome and proteome on cancer researches
[25-27].
For a long time, Chinese people have used many herbs
and prescriptions to treat asthma and airway inflamma-
tion. In Chinese medical science, several prescriptions
h a v eb e e na v a i l a b l ef o rs u p p o r t i v ec a r ea g a i n s tt h ed i s -
eases caused by the patients’ own immune system.
Asthma sufferers can be treated by supporting
approaches to regulate the whole body’si m m u n i t y ,b u t
these strategies are too slow to respond effectively in
the emergent events. In this report, we characterized
some of the Chinese herbs which inhibited interactions
between ECP and the airway epithelial cell line so that
the cytotoxicity of ECP might be reduced or eliminated.
According to the wet lab experimental data, we gener-
ated Chinese herbal combinative network to identify the
node herbs which were the components of effective pre-
scriptions. In total 83 kinds of Chinese prescriptions
and herbs recommended by Chinese medical doctors
were screened using ELISA method. The decrease in
binding affinity between ECP and bronchial epithelial
cells could be quantified. Moreover, the effective
Chinese herbs also inhibited the ECP translocating into
Beas-2B cells at very low concentration. Most of the
major compounds of effective Chinese herbs also
showed inhibitory effects on reducing the binding affi-
nity between ECP and cells. They may serve as the
potent drugs for the development of anti-asthma or
anti-inflammation treatments.
Results and discussions
The pre-screening of Chinese herbs
In the first step, thousands of Chinese herbs and pre-
scriptions were prescreened by Chinese medical doctors.
After prescreening, two herbal sets containing 90 and 83
kinds of herbs or prescriptions were selected and pur-
chased from Sun Ten Pharmaceutical Co. Ltd. and
Chuang Song-Zong Pharmaceutical Co. Ltd., separately.
Because of the manufacture process, the single-herbal
drugs and prescriptions from Chuang Song-Zong Com-
pany were boiled, cooled and concentrated to viscous
formulation; however, the drugs from Sun Ten Com-
pany appeared clear. After ELISA analysis, the drugs
from Sun Ten Company showed less effect on inhibiting
the ECP-cell interactions, possibly due to the difference
between the two manufacture processes. As a result, the
herbs produced by Chuang Song-Zong Company were
screened to select the effective candidates for reducing
the binding affinity of ECP and cells. The English and
Chinese names of herbs used in this study was listed in
Additional file 1.
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Page 3 of 11Eleven herbs and prescriptions reduced 90% of the ECP-
cell affinity
The cell-based ELISA platform is employed to screen
for drugs that can reduce or inhibit the interactions
between ECP and Beas-2B cells. It is expected that the
cytotoxicity of ECP can be inhibited via blockage of the
ECP-cell interactions. ECP was tagged with MBP for
antibody probing in the ELISA process. As shown in
Fig. 1 A ,M B P - E C P ,c o m p a r e dw i t hM B P ,s i g n i f i c a n t l y
bound to cells in a concentration-dependent way. Prior
to ELISA, 83 herbs or prescriptions were individually
mixed with 100 nM MBP-ECP recombinant proteins to
a final concentration of 0.1% (w/v) in RPMI-1640
serum-free media. The relative binding affinity normal-
ized by MBP-ECP-cell binding strength was measured
and calculated (Most of data is not shown and partial
data is in Fig. 1B). As shown in Fig. 2, the herbs and
prescriptions were classified into 5 groups according to
the relative reductive folds of ECP-cell binding affinity.
Five herbs and 6 prescriptions reduced 90% of the affi-
nity in ECP-cell interaction (Fig. 1B); however, Fig. 1B
also indicated that although 11 herbs inhibited ECP-cell
interaction most effectively, some other herbs also
reduced interactions significantly. In order to verify the
effectiveness of drugs, the central 11 herbs or prescrip-
tions listed in Fig. 2 were analyzed afterwards. As they
were diluted to a final concentration of 0.01%, most of
these drugs, excluding Wei-ling-sian, still reduced ECP-
cell interaction significantly (Fig. 1C).
Gan-cao, Sheng-si-huang, Dan-guei and Mu-tong were
potential for inhibiting the ECP-cell interactions
The 83 drugs were divided into two groups: single herbs
and prescriptions. Cross comparison provided useful
information to verify the effective herb for further inves-
tigation. According to the ELISA results, Gan-cao and
Figure 2 Classification of Chinese herbs inhibiting the interactions between ECP and Beas-2B cells. The inhibitory effect is classified into
5 groups from less than 10% to 80% as indicated. The most effective drugs containing 5 herbs and 6 prescriptions were zoomed in as illustrated.
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Page 4 of 11Sheng-di-huang appeared in 5, Dan-guei in 4 and
Mu-tong in 3 of the 6 prescriptions (Fig. 3), among
which Gan-cao displayed the most potential. In the
combinative network, Gan-cao served as a node linked
to prescriptions, Dao-chih-san, Long-dan-sie-gan-tang,
Siao-fong-san, Sie-fu-jhu-yu-tang and Yin-ciao-san, and
it could reduce 90% of ECP-cell affinity at a low concen-
tration of 0.1% (w/v). Although in the Chinese medicine
concept, Gan-cao is “Shi”, which plays a role in assisting
the sound effects of “Zuo” herbs, it may play a novel
role in mitigating the symptoms of inflammation.
Besides Gan-cao, another node, Sheng-di-huang, also
appeared in 5 prescriptions and reduced approximately
80% of the ECP-cell binding affinity at a concentration
of 0.1% (w/v) (Fig. 4). Consequently, it may serve as a
new candidate for inflammation treatment. Dan-guei
and Mu-tong were two nodes in the combinative herbal
network. However, they were not selected by Chinese
medical doctors in the pre-screening processes. After
the cell-based ELISA was performed, Dan-guei and
Mu-tong at a concentration of 0.1% (w/v) exactly
decreased the affinity between ECP and Beas-2B cells to
Figure 3 The network combined with herbs and prescriptions. The herbal prescriptions are gathered and boxed. Each herb is separately
shown in yellow, green, dark orange and light orange boxes, which means Jun, Chen, Zuo and Shi, respectively. The consensus herbs in
prescriptions are linked and connected as nodes. The relative fold of the inhibition of ECP-cell interactions is shown in red numerals.
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Page 5 of 1124.4% and 16.8%, respectively (Fig. 4). According to the
results of Dan-guei and Mu-tong, it is demonstrated
that our approaches to analyzing the combinative net-
work of the herbs can identify effective drugs from the
complex prescription formula.
The inhibition of ECP translocating into Beas-2B cells
According to the cell-based ELISA experiments and
the analysis of combinative network, 8 herbs, Tao-ren,
Sie-cao, Wei-ling-sian, Gan-cao, Jhih-mu, Dang-guei,
Sheng-di-huang, Mu-tong, reduced the binding affinity
between ECP and cells. Therefore, they should inhibit
ECP translocating into Beas-2B cells. MBP-ECP was
mixed with herbal extracts at a concentration of 0.1%
(Fig. 5A) or 0.01% (Fig. 5 B )a n di n c u b a t e dw i t ht h e
Beas-2B cells for 1 hr. Employing the immunofluores-
cent technique, MBP-ECP was traced using anti-MBP
antibodies and shown through green fluorescence. In
the treatment with 0.1% herbal extracts, all of the 8 her-
bal extracts inhibited the translocation of ECP into
Beas-2B cells. Sheng-di-huang, Dang-guei and Mu-tong
under the treatment at a concentration of 0.01% showed
less inhibitory effect on ECP translocation. It is pro-
posed that different herbs inhibited ECP translocation
under different concentrations with various components.
As a result, the major components of some effective
Chinese herbs were selected for further investigation.
The major components of herbs inhibited the interaction
of ECP and Beas-2B cells
Chinese herbs have been studied for a long time and
some major components can be purchased from com-
mercial chemical companies. Listed in Table 1, most of
the major components are carbohydrate, such as sugars
and acids. Previous studies have shown that ECP
interacts with proteoglycan, heparin sulfate, and condro-
tin sulfate [12,24]. It meant the major components
derived from Chinese herbs might inhibit the ECP-cell
interaction effectively. Fig. 6 shows at a concentration
of 50 nM, the major components of herbs decreased
40%-70% binding affinity between ECP and cells.
Among them, the major components of Gang-cao and
Sheng-di-huang, glycyrrhizic acid and verbascose,
respectively, showed the most efficient inhibition
towards ECP-cell interactions. Because the decrease of
binding affinity between ECP and cells was similarly
ranging from 0.05-1.6 μM( Additional file 2), other
components of herbs, which we did not characterize,
might play potential roles in interacting with ECP and
preventing ECP binding with cells.
In Chinese prescription, the herbs are separated into 4
parts, Jun, Chen, Zuo and Shi; Jun is the major drug
entity to target a disease; Chen either supports Jun or
reduces the side effects of Jun; Zuo makes Jun and
Chen stronger; it reduces the adverse effects or elimi-
nates the toxicity of Jun and Chen; Shi harmonizes the
total herbs or guides the herbs to the target effectively
[28]. Although Gang-cao plays the role as Shi, and
Sheng-di-huang plays as Jun, Chen, and Zuo in some
prescriptions, they may have the potential to be devel-
oped as anti-airway inflammation drugs to prevent air-
way damage. After the major effective compounds are
identified, we may adapt the concept of Jun, Chen, Zuo
and Shi to develop combinative drugs or formulations
to make drugs more efficient, effective and safe.
Conclusions
It is important to develop an approach for analyzing the
complex components of tranditional herbs or prescrip-
tions. This paper provides a methodological concept to
select the potential single herbs from several effective
prescriptions. Employing the same strategy and combi-
native network, we may select the potential compounds
f r o mae f f e c t i v eh e r b .H e r e ,w ei d e n t i f i e dt h em a j o r
components of Gan-cao and Sheng-di-huang which
inhibited the interactions of ECP and Beas-2B cells.
These compounds might serve as potential drugs to res-
cue airway epithelial cells damaged by ECP.
Materials and methods
The flowchat
Drug screening approaches provided clear information
to validate the efficacy of each drug candidate. However,
it is costly and time-consuming. Our methodology used
in this study combined with wet and dry lab methods to
screen the potential drugs which could inhibit the inter-
action between ECP and bronchial cells. Drug prescre-
ening by tranditional medical doctor cut down the
number of drug candidates to 173. Cell-based ELISA
Figure 4 The binding affinity between ECP and cells is
decreased by adding Sheng-di-hunag, Dang-guei and Mu-tong.
Compared with MBP-ECP control, the decrease of binding affinity is
significant (P<0.001). Each experiment is triplicated.
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Page 6 of 11Figure 5 MBP-ECP tanslocation is inhibited by the Chinese herbs. The recombinant MBP-ECP (200 nM) is pre-incubated with Chinese herbs
at a concentration of 0.1% (A) and 0.01% (B). The nucleus is in blue and MBP-ECP in green.
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tive herbs. The combinative network analysis presented
the node herbs which might play an important role in
inhibiting the ECP-cell binding. At last, the major com-
pounds of effective herbs were selected to detect the
inhibitive activity towards ECP-cell interaction (Fig. 7).
Antibodies and reagents
Antibodies were obtained from the following sources:
mouse anti-MBP from Santa Cruz Biotechnology (USA);
Goat anti-mouse HRP-from Jackson (USA); Goat anti-
mouse FITC-conjugated from Abcam (USA); Hoechst
33342 from Molecular Probes (USA); RPMI 1640 med-
ium from Sigma-Aldrich (USA); fetal bovine serum
(FBS) from Gibco/Invitrogen (USA) and tetramethylben-
zidine (TMB) from KPL (USA).
Cells and cell culture
Beas-2B, a human bronchial epithelial cell line (ATCC
CRL-9609), was cultured in RPMI-1640 medium supple-
mented with 10% heat-inactivated fetal bovine serum at
37°C in an incubator containing 5% CO2 and 95% air.
Purification of recombinant proteins
The pMAL-c2X-ECP was transformed into E. coli BL 21
(DE3) pLysS (Novagen, USA) for protein expression.
Twenty milliliters of the culture grown overnight were
inoculated into 500 ml of LB media containing 100 µg/
ml carbenicillin (Sigma-Aldrich, USA) and 50 µg/ml
chloramlphenicol (Sigma-Aldrich, USA), followed by
incubation at 37°C for 6 hr till the OD600 reacb-D-1-
thiogalactopyranoside (IPTG) (Ameresco, German) was
added to a final concentration of 1 mM, and the bac-
teria were harvested after a 4-hr induction at 30°C.
Recombinant MBP-ECP was fractioned in the soluble
portion of bacterial lysate. MBP-ECP was purified using
amylose affinity chromatography (NEB, UK) and
switched to PBS buffer. To remove the impurity, heparin
affinity chromatography was utilized. Then, MBP-ECP
was eluted using 100 mM phosphate buffer (pH 7.4)
containing 1 M NaCl. The purified MBP-ECP was con-
centrated and the buffer was changed to PBS by Amicon
Ultra-15. The protein concentration of MBP-ECP was
determined by BCA assay kit (Pierce, USA) and the
MBP was also purified and served as the negative con-
trol for cell-based ELISA.
Preparation of Chinese herbs
The extracts of Chinese herbs were viscous, so they
were diluted into distilled water to a final concentration
of 10% (w/v). Afterwards, the mixture was centrifuged at
12,000 g at 4°C for 20 min, and the supernatant was
transferred to a new tube and stored at -20°C. In the
cytotoxcity assay, the herbs were filtered by 0.22 μm.
Cell-based ELISA
The binding affinity between MBP-ECP and Beas-2B cells
in the presence of various Chinese herbs was measured
using cell-based ELISA. One microliter of the processed
herbs was diluted into 49 μl serum-free RPMI-1640 med-
ium containing 100 nM MBP-ECP. The Beas-2B cells
with 70% confluent monolayer in each well of a 96-well
plate (20,000 cells/well) were washed with PBS and
blocked with 2% BSA/PBS at 4°C for 1 hr. Next, the cells
were incubated in 50 μl serum-free media and mixed
with 50 μl herb/MBP-ECP mixture at 4°C for 1 hr. After
being washed with PBS, fixed with 2% PFA/PBS,
quenched with 50 mM NH4Cl and reblocked with 2%
BSA/PBS, the MBP-ECP was probed by mouse anti-MBP
mAb at 25°C for 1 hr and anti-mouse HRP-conjugated
secondary antibody was used to probe the anti-MBP
Table 1 Major components of Chinese herbs
Chinese Herbs Pharmaceutical species Major components
Gan-cao Glycyrrhizae Radix Glycyrrhizic acid
Tao-ren Prunus persica Batsch Allantoin
Tao-ren Prunus persica Batsch Maltose
Tao-ren Prunus persica Batsch Amygdalin
Sheng-di-huang Rehmanniae Radix et Rhizoma Aucubin
Sheng-di-huang Rehmanniae Radix et Rhizoma Stachyose
Sheng-di-huang Rehmanniae Radix et Rhizoma Verbascose
Sie-cao Valeriana officinalis Valeric acid
Figure 6 Binding affinity between ECP and cells is decreased
by adding the major components of the Chinese herbs.
Compared with MBP-ECP, the binding affinity of verbascose and
valeric acid are decreased significantly (** P<0.02) and stachyose
hydrate, maltose and glycyrrhizic acid are minor significant (*
P<0.06). Each experiment is duplicated.
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each well prior to incubation for 10 min in the dark.
After terminating the reaction by adding 100 μl2 NH C l ,
the absorbance for 450 nm was measured using ELSA
reader (Biotek, Australia). The A450 value indicating the
interaction between MBP-ECP and cells was set as 100%
and the relative fold of ECP-cell binding reduction was
calculated using Microsoft Office Excel 2007.
Drug treatment
Beas-2B cells were seeded on coverslips into 24-well cul-
ture plates (100,000/well) in RPMI 1640 medium con-
taining 10% FBS and incubated for 2 days to form a
monolayer at the bottom of plates. In addition, cells
were incubated at 37°C for 1 day in serum-free RPMI
1640 medium for serum starvation. Eight herbal
extracts, Tao-ren, Sie-cao, Wei-ling-sian, Gan-cao, Jhih-
mu, Dang-guei, Sheng-di-huang, Mu-tong, at concentra-
tions of 0.1% or 0.01% (w/v) were mixed with 200 nM
MBP-ECP for 30 min at room temperature and treated
with Beas-2B cells at 37°C for 1 hr. The major compo-
nent of Chinese herbs listed in Table 1 was also tested
at concentrations of 0.05-1.6 μM.
Generation of combinative network
A combinative network was generated according to the
ELISA screening results. Each herb of the prescriptions
was listed and boxed. The network was generated using
CellDesigner 4.0.1 [29] and modified using Microsoft
Office Powerpoint 2007.
Figure 7 The flowchat of this study.
Chang et al. BMC Systems Biology 2010, 4(Suppl 2):S8
http://www.biomedcentral.com/1752-0509/4?issue=S2/S8
Page 9 of 11Immuno-fluorescence staining and confocal microscopy
After drug treatment, cells were extensively washed with
PBS, fixed with 2% paraformaldehyde (PFA) in PBS for
15 min, quenched with 50 mM NH4Cl in PBS for 10
min, and then permeabilized with 0.5% (v/v) Triton-X-
100 for 5 min at room temperature in turn. The cells
were blocked with 2% BSA in PBS for 30 min at room
temperature, and labeled with primary antibodies diluted
in 0.5% BSA in PBS for 1 hr at 25°C, followed by wash-
ing two times with 0.05% (v/v) Triton-X-100 and one
time with PBS, and then incubated with secondary anti-
bodies diluted in 0.5% BSA in PBS for 1 h at 25°C.
Nuclei were stained with Hoechst 33342 during the last
5 min of incubation. Cells were then washed two times
with 0.05% Triton-X-100 and one time with PBS, and
coverslips were mounted by ProLong® Gold antifade
reagent (Invetrogen). Confocal microscopy was per-
formed employing an Axiovert (Zeiss) confocal micro-
scope using the 63 × Plan-NEOFLUAR oil immersion
objective.
Additional file 1: The English and Chinese names of herbs used in this
study.
Additional file 2: Relative binding affinity between ECP and cells is
decreased by adding different concentrations of the major components
of the Chinese herbs. Each experiment is duplicated.
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